Page last updated: 2024-08-21

c.i. 42510 and propofol

c.i. 42510 has been researched along with propofol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, XF; Li, JB; Liu, J; Ni, W1
Asano, N; Ikemoto, K; Ishiyama, T; Kotoda, M; Matsukawa, T; Mitsui, K; Sato, H; Sessler, DI1

Trials

1 trial(s) available for c.i. 42510 and propofol

ArticleYear
The effects of Patent Blue dye on peripheral and cerebral oxyhaemoglobin saturations.
    Anaesthesia, 2015, Volume: 70, Issue:4

    Topics: Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Artifacts; Breast Neoplasms; Cerebrovascular Circulation; Coloring Agents; Diagnostic Errors; Female; Humans; Methyl Ethers; Middle Aged; Monitoring, Intraoperative; Oximetry; Oxyhemoglobins; Propofol; Rosaniline Dyes; Sevoflurane

2015

Other Studies

1 other study(ies) available for c.i. 42510 and propofol

ArticleYear
Effects of propofol on P2X7 receptors and the secretion of tumor necrosis factor-α in cultured astrocytes.
    Clinical and experimental medicine, 2012, Volume: 12, Issue:1

    Topics: Adenosine Triphosphate; Animals; Astrocytes; Cells, Cultured; Electrophysiological Phenomena; Enzyme-Linked Immunosorbent Assay; Neuroglia; Neuroprotective Agents; Patch-Clamp Techniques; Propofol; Purinergic P2X Receptor Agonists; Rats; Receptors, Purinergic P2X7; Rosaniline Dyes; Time Factors; Tumor Necrosis Factor-alpha

2012